Jan 11, 2021 / 08:40PM GMT
Cory William Kasimov - JPMorgan Chase & Co, Research Division - Senior Biotechnology Analyst
All right. Good afternoon, everyone, from the virtual JPMorgan Healthcare Conference. My name is Cory Kasimov. I'm the senior large-cap biotech analyst, and it's my pleasure to introduce our next company, Gilead, and Chairman and CEO, Dan O'Day.
Please note that following this presentation, we will have a Q&A session right here in the same Zoom room, and you're able to submit your own questions via the little blue ask-a-question button in the conference portal. So please do that throughout the presentation. We'll get to as many as we can after Dan is finished.
So with that, Dan, thanks for being here today, and let me turn things over to you.
Daniel P. O'Day - Gilead Sciences, Inc. - Chairman & CEO
Great. Thanks, Cory and JPMorgan, for hosting us here. Really appreciate the opportunity to speak to you about Gilead. It is -- just 1 year ago, that was my first JPMorgan with Gilead, and a lot has happened in that year time,
Gilead Sciences Inc at JPMorgan Healthcare Conference (Virtual) Transcript
Jan 12, 2021
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers